DGAP-Adhoc Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast
Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
Osaka, Japan, February 4, 2021 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") announced today, the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2021*1, as below.
1. Revised Forecast for Full Year Consolidated Financials for the Fiscal Year Ending March 31, 2021
(millions of yen)
Net profit attributable
to owners of
|Previous Forecast (A)***||3,250,000||984,000||434,000||258,000||124,000||79.39 yen||420 yen|
|Revised Forecast (B)||3,250,000||984,000||434,000||258,000||180,500||115.56 yen||420 yen|
*** Announced on October 29, 2020.